These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 174434)

  • 1. The relation of infection with the hepatitis B agent to primary hepatic carcinoma.
    Blumberg BS; Larouzé B; London WT; Werner B; Hesser JE; Millman I; Saimot G; Payet M
    Am J Pathol; 1975 Dec; 81(3):669-82. PubMed ID: 174434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The relation of infection with the hepatitis B-agent to primary hepatic carcinoma (author's transl)].
    Blumberg BS; Larouzé B; London WT; Werner B; Hesser JE; Millman I; Saimot G; Payet M
    Leber Magen Darm; 1976 Dec; 6(6):309-15. PubMed ID: 190499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hepatitis B and primary cancer of the liver in intertropical Africa].
    Coursaget P; Yvonnet B; Barres JL; Perrin J; Tortey E; Diop B; Kocheleff P; Duflo B; M'Boup S; Diop-Mar I
    Rev Epidemiol Sante Publique; 1985; 33(4-5):267-75. PubMed ID: 2419946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hepatocellular carcinoma, hepatitis B virus and the immune system].
    Grob PJ
    Schweiz Med Wochenschr; 1986 Aug; 116(34):1133-45. PubMed ID: 3020684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B virus and primary hepatocellular carcinoma: family studies in Korea.
    Hann HW; Kim CY; London WT; Whitford P; Blumberg BS
    Int J Cancer; 1982 Jul; 30(1):47-51. PubMed ID: 6288579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B vaccination: an important method of preventing HBV-related hepatocellular carcinoma.
    Zanetti A
    Ital J Gastroenterol; 1992 Feb; 24(2):100-2. PubMed ID: 1315589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot study on universal immunization of newborn infants in an area of hepatitis B virus and primary hepatocellular carcinoma prevalence with a low dose of hepatitis B vaccine.
    Sun TT; Chu YR; Ni ZQ; Lu JH; Huang F; Ni ZP; Pei XF; Yu ZI; Liu GT
    J Cell Physiol Suppl; 1986; 4():83-90. PubMed ID: 3018008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B virus e antigen and primary hepatocellular carcinoma.
    Lin TM; Chen CJ; Lu SN; Chang AS; Chang YC; Hsu ST; Liu JY; Liaw YF; Chang WY
    Anticancer Res; 1991; 11(6):2063-5. PubMed ID: 1663719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
    Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
    Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features of HBsAg-negative but anti-HBc-positive hepatocellular carcinoma in a hepatitis B virus endemic area.
    Shim J; Kim BH; Kim NH; Dong SH; Kim HJ; Chang YW; Lee JI; Chang R
    J Gastroenterol Hepatol; 2005 May; 20(5):746-51. PubMed ID: 15853989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroprevalence of hepatitis B and C viral markers in patients with primary hepatocellular carcinoma in Singapore.
    Khin LW; Teo CJ; Guan R
    Singapore Med J; 1996 Oct; 37(5):492-6. PubMed ID: 9046201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
    Kim MJ; Kwon OS; Chung NS; Lee SY; Jung HS; Park DK; Ku YS; Kim YK; Kim YS; Kim JH
    Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody to hepatitis B core antigen in patients with hepatocellular carcinoma.
    Kubo Y; Okuda K; Hashimoto M; Nagasaki Y; Ebata H
    Gastroenterology; 1977 Jun; 72(6):1217-20. PubMed ID: 192626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus and the control of hepatocellular carcinoma.
    Blumberg BS
    IARC Sci Publ; 1984; (63):243-61. PubMed ID: 6100273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of hepatitis B virus infection in children born to HBsAg positive/HBeAg positive mothers. Preliminary results of active and passive-active immunization.
    Goudeau A; Lo KJ; Coursaget P; Tong MJ; Yeh CL; Tsai YT; Lee JK; Wu TC; Yeh SH; Lee SD
    Dev Biol Stand; 1983; 54():399-404. PubMed ID: 6228473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus serological markers in Africans with liver cirrhosis and hepatocellular carcinoma.
    Coursaget P; Chiron JP; Barres JL; Barin F; Cottey P; Tortey E; Yvonnet B; Diop B; MBoup S; Diop-Mar I
    IARC Sci Publ; 1984; (63):181-98. PubMed ID: 6085625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B viral markers in patients with primary hepatocellular carcinoma in Taiwan.
    Chien MC; Tong MJ; Lo KJ; Lee JK; Milich DR; Vyas GN; Murphy BL
    J Natl Cancer Inst; 1981 Mar; 66(3):475-9. PubMed ID: 6162990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients.
    Chen CH; Hung CH; Lee CM; Hu TH; Wang JH; Wang JC; Lu SN; Changchien CS
    Gastroenterology; 2007 Nov; 133(5):1466-74. PubMed ID: 17915220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current status and therapeutic strategy for hepatocellular carcinoma].
    Unoura M; Adachi K; Kawai H; Inagaki Y; Kaneko S; Kobayashi K
    Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 1):608-14. PubMed ID: 2157367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B x antigen in hepatitis B virus carrier patients with liver cancer.
    Wang WL; London WT; Feitelson MA
    Cancer Res; 1991 Sep; 51(18):4971-7. PubMed ID: 1654208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.